The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
A Pituitary-Derived MEG3 Isoform Functions as a Growth Suppressor in Tumor Cells
Abstract
Human pituitary adenomas are the most common intracranial neoplasm. Typically monoclonal in origin, a somatic mutation is a prerequisite event in tumor development. To identify underlying pathogenetic mechanisms in tumor formation, we compared the difference in gene expression between normal human pituitary tissue and clinically nonfunctioning pituitary adenomas by cDNA-representational difference analysis. We cloned a cDNA, the expression of which was absent in these tumors, that represents a novel transcript from the previously described MEG3, a maternal imprinting gene with unknown function. It was expressed in normal human gonadotrophs, from which clinically nonfunctioning pituitary adenomas are derived. Additional investigation by Northern blot and RT-PCR demonstrated that this gene was also not expressed in functioning pituitary tumors as well as many human cancer cell lines. Moreover, ectopic expression of this gene inhibits growth in human cancer cells including HeLa, MCF-7, and H4. Genomic analysis revealed that MEG3 is located on chromosome 14q32.3, a site that has been predicted to contain a tumor suppressor gene involved in the pathogenesis of meningiomas. Taken together, our data suggest that MEG3 may represent a novel growth suppressor, which may play an important role in the development of human pituitary adenomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathology and genetics of tumours of the nervous system.
Kleihues, P., & Cavennee, W. (2000) · International Agency for Research on Cancer eBooks · Cited by 1,432
Notch signalling controls pancreatic cell differentiation
Apelqvist, Å., Li, H., Sommer, L., Beatus, P., Anderson, D. J., Honjo, T., de Angelis, M. H., Lendahl, U., & Edlund, H. (1999) · Nature · doi:10.1038/23716 · Cited by 1,159
Takekawa, M., & Saito, H. (1998) · Cell · doi:10.1016/s0092-8674(00)81619-0 · Cited by 746
Isolation and Characterization of a Pituitary Tumor-Transforming Gene (PTTG)
Pei, L. (1997) · Molecular Endocrinology · doi:10.1210/me.11.4.433 · Cited by 576
Pituitary Tumor Transforming Gene (PTTG) Expression in Pituitary Adenomas
Zhang, X. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.2.761 · Cited by 440
Self-citationWeber, R. G., Boström, J., Wolter, M., Baudis, M., Collins, V. P., Reifenberger, G., & Lichter, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14719 · Cited by 407
The Cytogenesis and Pathogenesis of Pituitary Adenomas*
Asa, S. L., & Ezzat, S. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0350 · Cited by 388
Miyoshi, N., Wagatsuma, H., Wakana, S., Shiroishi, T., Nomura, M., Aisaka, K., Kohda, T., Surani, M. A., Kaneko‐Ishino, T., & Ishino, F. (2000) · Genes to Cells · doi:10.1046/j.1365-2443.2000.00320.x · Cited by 384
Clinically nonfunctioning pituitary tumors are monoclonal in origin.
Alexander, J. M., Biller, B. M., Bikkal, H., Zervas, N. T., Arnold, A., & Klibanski, A. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114705 · Cited by 366
Self-citationStructure, Expression, and Function of Human Pituitary Tumor-Transforming Gene (PTTG)
Zhang, X., Horwitz, G. A., Prezant, T. R., Valentini, A., Nakashima, M., Bronstein, M. D., & Melmed, S. K. (1999) · Molecular Endocrinology · doi:10.1210/me.13.1.156 · Cited by 324
Self-citation
Cited by
The functional role of long non-coding RNA in human carcinomas
Gibb, E. A., Brown, C. J., & Lam, W. L. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-38 · Cited by 1,619
Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer
Mármol, I., Sánchez-de-Diego, C., Pradilla Dieste, A., Cerrada, E., & Rodriguez Yoldi, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010197 · Cited by 1,525
Long non-coding RNAs: A new frontier in the study of human diseases
Shi, X., Sun, M., Liu, H., Yao, Y., & Song, Y. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.06.013 · Cited by 1,150
MEG3 noncoding RNA: a tumor suppressor
Zhou, Y., Zhang, X., & Klibanski, A. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0008 · Cited by 716
Self-citationRapid evolution of noncoding RNAs: lack of conservation does not mean lack of function
Pang, K. C., Frith, M. C., & Mattick, J. S. (2006) · Trends in Genetics · doi:10.1016/j.tig.2005.10.003 · Cited by 656
Activation of p53 by MEG3 Non-coding RNA
Zhou, Y., Zhong, Y., Wang, Y., Zhang, X., Batista, D. L., Gejman, R., Ansell, P. J., Zhao, J., Weng, C., & Klibanski, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702029200 · Cited by 653
Self-citationmicroRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer
Braconi, C., Kogure, T., Valeri, N., Huang, N., Nuovo, G., Costinean, S., Negrini, M., Miotto, E., Croce, C. M., & Patel, T. (2011) · Oncogene · doi:10.1038/onc.2011.193 · Cited by 642
Long non-coding RNAs and complex diseases: from experimental results to computational models
Chen, X., Yan, C. C., Zhang, X., & You, Z.-H. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw060 · Cited by 567
Self-citationLarge non-coding RNAs: missing links in cancer?
Huarte, M., & Rinn, J. L. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq353 · Cited by 484
Amaral, P. P., & Mattick, J. S. (2008) · Mammalian Genome · doi:10.1007/s00335-008-9136-7 · Cited by 480
Function of lncRNAs and approaches to lncRNA-protein interactions
Zhu, J., Fu, H., Wu, Y., & Zheng, X. (2013) · Science China Life Sciences · doi:10.1007/s11427-013-4553-6 · Cited by 387
Long noncoding RNAs: Novel insights into hepatocelluar carcinoma
He, Y., Meng, X.-M., Huang, C., Wu, B.-M., Zhang, L., Lv, X.-W., & Li, J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.10.021 · Cited by 385
Human Cancer Long Non-Coding RNA Transcriptomes
Gibb, E. A., Vucic, E. A., Enfield, K. S. S., Stewart, G. L., Lonergan, K. M., Kennett, J. Y., Becker-Santos, D. D., MacAulay, C. E., Lam, S., Brown, C. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025915 · Cited by 364
The functional role of long non-coding RNAs and epigenetics
Cao, J. (2014) · Biological Procedures Online · doi:10.1186/1480-9222-16-11 · Cited by 357
Piccoli, M.-T., Gupta, S. K., Viereck, J., Foinquinos, A., Samolovac, S., Kramer, F. L., Garg, A., Remke, J., Zimmer, K., Batkai, S., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.310624 · Cited by 344
Long non-coding RNA expression profiles predict clinical phenotypes in glioma
Zhang, X., Sun, S., Pu, J. K. S., Tsang, A. C. O., Lee, D., Man, V. O. Y., Lui, W. M., Wong, S. T. S., & Leung, G. K. K. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.06.004 · Cited by 341
Self-citationOverexpression of the long non‐coding RNA MEG3 impairs in vitro glioma cell proliferation
Wang, P., Ren, Z., & Sun, P. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24055 · Cited by 340
Zhang, X., Gejman, R., Mahta, A., Zhong, Y., Rice, K. A., Zhou, Y., Cheunsuchon, P., Louis, D. N., & Klibanski, A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3885 · Cited by 330
Self-citationZhang, X., Rice, K., Wang, Y., Chen, W., Zhong, Y., Nakayama, Y., Zhou, Y., & Klibanski, A. (2010) · Endocrinology · doi:10.1210/en.2009-0657 · Cited by 325
Self-citationNovel classes of non-coding RNAs and cancer
Sana, J., Faltejskova, P., Svoboda, M., & Slaby, O. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-103 · Cited by 304
Regulation of lncRNA and Its Role in Cancer Metastasis
Li, J., Meng, H., Bai, Y., & Wang, K. (2016) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504016x14549667334007 · Cited by 297
Long non-coding RNAs in ischemic stroke
Bao, M.-H., Szeto, V., Yang, B. B., Zhu, S.-Z., Sun, H.-S., & Feng, Z.-P. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0282-x · Cited by 285
MEG3 imprinted gene contribution in tumorigenesis
Benetatos, L., Vartholomatos, G., & Hatzimichael, E. (2011) · International Journal of Cancer · doi:10.1002/ijc.26052 · Cited by 271
Long Non-coding RNAs in Cancer: Implications for Diagnosis, Prognosis, and Therapy
Qian, Y., Shi, L., & Luo, Z. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.612393 · Cited by 261
Long noncoding RNA MEG3 activation of p53 mediates ischemic neuronal death in stroke
Yan, H., Yuan, J., Gao, L., Rao, J., & Hu, J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.09.017 · Cited by 142
Involvement of long noncoding RNAs in diseases affecting the central nervous system
Pastori, C., & Wahlestedt, C. (2012) · RNA Biology · doi:10.4161/rna.20482 · Cited by 100
Expanding the p53 regulatory network: LncRNAs take up the challenge
Grossi, E., Sánchez, Y., & Huarte, M. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.07.011 · Cited by 78
LncRNA MEG3 Regulates Imatinib Resistance in Chronic Myeloid Leukemia via Suppressing MicroRNA-21
Zhou, X., Yuan, P., Liu, Q., & Liu, Z. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2016.162 · Cited by 78
“Loss of MEG3 has been shown in various human cancers, including brain, bladder, bone marrow, breast, colon and liver cancers, and exogenous expression of MEG3 significantly suppresses the proliferation of human cancer cells (Zhang et al., 2003, 2010).”
BackgroundXiao, X., Zhu, W., Liao, B., Xu, J., Gu, C., Ji, B., Yao, Y., Peng, L., & Yang, J. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00411 · Cited by 47
Metadata
- Authors
- Zhang, X., Zhou, Y., Mehta, K. R., Danila, D. C., Scolavino, S., Johnson, S. R., & Klibanski, A.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-11-01
- Volume
- 88
- Issue
- 11
- Pages
- 5119-5126
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2164252048
- Cited by
- 435
- References
- 37
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.